Cell and gene therapies require 6–15 years of follow-up to monitor long-term safety and efficacy. Traditional sites can struggle to sustain contact and compliance over such extended timelines. This guide shows how decentralized solutions make long-term follow-up (LTFU) more sustainable, efficient, and patient-centric.
In this guide, you’ll learn:
- Why LTFU is critical in CGT development
- The challenges of site-based follow-up
- How DCT models improve continuity and compliance
Download the Guide
By submitting your information to us through this webform, your business details will be added to our database. In accordance with our Privacy Notice, we may then contact you with marketing information about Premier Research that might be of interest to you. We will never sell your details to third parties. You can unsubscribe from marketing communications at any time.